A New Era of Precision
and Personalization
in Transplant Care

Antibody image



Cell-free DNA

Blood Assessment

biopsy tissue image

mRNA Expression

Biopsy Assessment

Your patients rely on you for comprehensive treatment to ensure the long-term success of their transplants. 
Make sure you have the most advanced tools for the job.

Post-transplant monitoring tools for early detection


A suite of post-transplant monitoring tools are offered for early detection of donor-specific antibodies and a range of rejection types as well as the quantitative analysis of biopsies. These combined tools will provide precise information, smarter analyses, and unequivocal results so that you can manage your patients with confidence. ​


As the gold standard of care, DSA monitoring reliably stratifies information about patient antibody levels.

Cell-free DNA

For early detection, high accuracy dd-cfDNA testing with Prospera™ Transplant Assessment Test will further improve the standard of care.

mRNA Expression

When rejection is detected, MMDx will assess ABMR, TCMR, or injury with mRNA profiling and machine learning algorithms. 

In the News


  • ProActive™ Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients 
    (... read more)

ISHLT 2020
Industry Theatre Session
Personalizing Care in Transplant Diagnostics: Connecting DSA Monitoring and MMDx

APR 22 | 12:30 - 1: 30PM

© 2017-2019 by Thermo Fisher Scientific Inc.

  • Black LinkedIn Icon
  • Black Twitter Icon